- call +1-201-465-4211
- email sales@mrinsights.biz
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
According to this study, over the next five years the Cardiac Biomarkers Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cardiac Biomarkers Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cardiac Biomarkers Testing market by product type, application, key companies and key regions.
This study considers the Cardiac Biomarkers Testing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. HOFFMANN-LA ROCHE LTD.
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cardiac Biomarkers Testing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cardiac Biomarkers Testing market by identifying its various subsegments.
Focuses on the key global Cardiac Biomarkers Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cardiac Biomarkers Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cardiac Biomarkers Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Cardiac Biomarkers Testing Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiac Biomarkers Testing Market Size 2014-2024
2.1.2 Cardiac Biomarkers Testing Market Size CAGR by Region
2.2 Cardiac Biomarkers Testing Segment by Type
2.2.1 Myocardial Muscle Creatine Kinase (CK-MB)
2.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
2.2.3 Myoglobin
2.2.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
2.2.5 Ischemia-modified Albumin (IMA)
2.2.6 Others
2.3 Cardiac Biomarkers Testing Market Size by Type
2.3.1 Global Cardiac Biomarkers Testing Market Size Market Share by Type (2014-2019)
2.3.2 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (2014-2019)
2.4 Cardiac Biomarkers Testing Segment by Application
2.4.1 Myocardial Infarction
2.4.2 Congestive Heart Failure
2.4.3 Acute Coronary Syndrome
2.4.4 Atherosclerosis
2.4.5 Others
2.5 Cardiac Biomarkers Testing Market Size by Application
2.5.1 Global Cardiac Biomarkers Testing Market Size Market Share by Application (2014-2019)
2.5.2 Global Cardiac Biomarkers Testing Market Size Growth Rate by Application (2014-2019)
3 Global Cardiac Biomarkers Testing by Players
3.1 Global Cardiac Biomarkers Testing Market Size Market Share by Players
3.1.1 Global Cardiac Biomarkers Testing Market Size by Players (2017-2019)
3.1.2 Global Cardiac Biomarkers Testing Market Size Market Share by Players (2017-2019)
3.2 Global Cardiac Biomarkers Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cardiac Biomarkers Testing by Regions
4.1 Cardiac Biomarkers Testing Market Size by Regions
4.2 Americas Cardiac Biomarkers Testing Market Size Growth
4.3 APAC Cardiac Biomarkers Testing Market Size Growth
4.4 Europe Cardiac Biomarkers Testing Market Size Growth
4.5 Middle East & Africa Cardiac Biomarkers Testing Market Size Growth
5 Americas
5.1 Americas Cardiac Biomarkers Testing Market Size by Countries
5.2 Americas Cardiac Biomarkers Testing Market Size by Type
5.3 Americas Cardiac Biomarkers Testing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cardiac Biomarkers Testing Market Size by Countries
6.2 APAC Cardiac Biomarkers Testing Market Size by Type
6.3 APAC Cardiac Biomarkers Testing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Cardiac Biomarkers Testing by Countries
7.2 Europe Cardiac Biomarkers Testing Market Size by Type
7.3 Europe Cardiac Biomarkers Testing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cardiac Biomarkers Testing by Countries
8.2 Middle East & Africa Cardiac Biomarkers Testing Market Size by Type
8.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Cardiac Biomarkers Testing Market Forecast
10.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
10.2 Global Cardiac Biomarkers Testing Forecast by Regions
10.2.1 Global Cardiac Biomarkers Testing Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cardiac Biomarkers Testing Forecast by Type
10.8 Global Cardiac Biomarkers Testing Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Cardiac Biomarkers Testing Product Offered
11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Becton, Dickinson and Company
11.2.1 Company Details
11.2.2 Cardiac Biomarkers Testing Product Offered
11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Becton, Dickinson and Company News
11.3 BioMerieux
11.3.1 Company Details
11.3.2 Cardiac Biomarkers Testing Product Offered
11.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 BioMerieux News
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Company Details
11.4.2 Cardiac Biomarkers Testing Product Offered
11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bio-Rad Laboratories, Inc. News
11.5 Danaher Corporation
11.5.1 Company Details
11.5.2 Cardiac Biomarkers Testing Product Offered
11.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Danaher Corporation News
11.6 F. HOFFMANN-LA ROCHE LTD.
11.6.1 Company Details
11.6.2 Cardiac Biomarkers Testing Product Offered
11.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 F. HOFFMANN-LA ROCHE LTD. News
11.7 Siemens AG
11.7.1 Company Details
11.7.2 Cardiac Biomarkers Testing Product Offered
11.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Siemens AG News
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Company Details
11.8.2 Cardiac Biomarkers Testing Product Offered
11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Thermo Fisher Scientific, Inc. News
11.9 PerkinElmer Inc.
11.9.1 Company Details
11.9.2 Cardiac Biomarkers Testing Product Offered
11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 PerkinElmer Inc. News
11.10 Tosoh Corporation
11.10.1 Company Details
11.10.2 Cardiac Biomarkers Testing Product Offered
11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Tosoh Corporation News
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Cardiac Biomarkers Testing
Figure Cardiac Biomarkers Testing Report Years Considered
Figure Market Research Methodology
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
